Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome

Psychoneuroendocrinology

Volumn 40, Issue 1, 2014, Pages 48-59

  Dinel, Anne Laure ^a,b   André, Caroline ^b,c   Aubert, Agnès ^a,b   Ferreira, Guillaume ^a,b   Layé, Sophie ^a,b   Castanon, Nathalie ^a,b  

^a NutriNeuro Bordeaux University   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

Cytokines; Db db mice; Depression; Forced swim test; Hippocampus; Indoleamine 2,3 dioxygenase; Lipopolysaccharide; Metabolic syndrome

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; LIPOPOLYSACCHARIDE; TRYPTOPHAN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CATABOLISM; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FORCED SWIM TEST; HIPPOCAMPUS; IMMOBILITY; INCIDENCE; INFLAMMATION; INNATE IMMUNITY; MALE; METABOLIC SYNDROME X; MOOD; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CYTOKINES; DB/DB MICE; DEPRESSION; FORCED SWIM TEST; HIPPOCAMPUS; INDOLEAMINE 2,3-DIOXYGENASE; LIPOPOLYSACCHARIDE; METABOLIC SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; LIPOPOLYSACCHARIDES; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; RECEPTORS, LEPTIN; TRYPTOPHAN;

EID: 84893400879     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.10.014     Document Type: Article

References (64)

1. André C., O'Connor J.C., Kelley K.W., Lestage J., Dantzer R., Castanon N. Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. J. Neuroimmunol. 2008, 200:90-99.
2. Bano S., Gitay M., Ara I., Badawy A. Acute effects of serotonergic antidepressants on tryptophan metabolism and corticosterone levels in rats. Pak. J. Pharm. Sci. 2010, 23:266-272.
3. Barrientos R.M., Sprunger D.B., Campeau S., Watkins L.R., Rudy J.W., Maier S.F. BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration. J. Neuroimmunol. 2004, 155:119-126.
4. Brandacher G., Hoeller E., Fuchs D., Weiss H.G. Chronic immune activation underlies morbid obesity: is IDO a key player?. Curr. Drug Metab. 2007, 8:289-295.
5. Brandacher G., Winkler C., Aigner F., Schwelberger H., Schroecksnadel K., Margreiter R., Fuchs D., Weiss H.G. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obes. Surg. 2006, 16:541-548.
6. Capuron L., Miller A.H. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther. 2011, 130:226-238.
7. Capuron L., Su S., Miller A.H., Bremner J.D., Goldberg J., Vogt G.J., Maisano C., Jones L., Murrah N.V., Vaccarino V. Depressive symptoms and metabolic syndrome: is inflammation the underlying link?. Biol. Psychiatry 2008, 64:896-900.
8. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
9. Castanon N., Konsman J.P., Medina C., Chauvet N., Dantzer R. Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation. Psychoneuroendocrinology 2003, 28:19-34.
10. Castanon N., Leonard B.E., Neveu P.J., Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain Behav. Immun. 2002, 16:569-574.
11. Castanon N., Medina C., Mormede C., Dantzer R. Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats. Psychoneuroendocrinology 2004, 29:778-790.
12. Corona A.W., Fenn A.M., Godbout J.P. Cognitive and behavioral consequences of impaired immunoregulation in aging. J. Neuroimmune Pharmacol. 2012, 7:7-23.
13. Corona A.W., Huang Y., O'Connor J.C., Dantzer R., Kelley K.W., Popovich P.G., Godbout J.P. Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J. Neuroinflammation 2010, 7:93.
14. Corona A.W., Norden D.M., Skendelas J.P., Huang Y., O'Connor J.C., Lawson M., Dantzer R., Kelley K.W., Godbout J.P. Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice. Brain Behav. Immun. 2013, 31:134-142.
15. Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111:1448-1454.
16. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
17. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
18. Dinel A.L., André C., Aubert A., Ferreira G., Laye S., Castanon N. Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS ONE 2011, 6:e24325.
19. Evans D.L., Charney D.S., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R., Nemeroff C.B., Bremner J.D., Carney R.M., Coyne J.C., Delong M.R., Frasure-Smith N., Glassman A.H., Gold P.W., Grant I., Gwyther L., Ironson G., Johnson R.L., Kanner A.M., Katon W.J., Kaufmann P.G., Keefe F.J., Ketter T., Laughren T.P., Leserman J., Lyketsos C.G., McDonald W.M., McEwen B.S., Miller A.H., Musselman D., O'Connor C., Petitto J.M., Pollock B.G., Robinson R.G., Roose S.P., Rowland J., Sheline Y., Sheps D.S., Simon G., Spiegel D., Stunkard A., Sunderland T., Tibbits P., Valvo W.J. Mood disorders in the medically ill: scientific review and recommendations. Biol. Psychiatry 2005, 58:175-189.
20. Faggioni R., Fantuzzi G., Gabay C., Moser A., Dinarello C.A., Feingold K.R., Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am. J. Physiol. 1999, 276:R136-R142.
21. Faggioni R., Fuller J., Moser A., Feingold K.R., Grunfeld C. LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. Am. J. Physiol. 1997, 273:R181-R186.
22. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., Kelley K.W., Dantzer R., Castanon N. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
23. Fu X., Zunich S.M., O'Connor J.C., Kavelaars A., Dantzer R., Kelley K.W. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J. Neuroinflammation 2010, 7:43.
24. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 2005, 5:243-251.
25. Godbout J.P., Moreau M., Lestage J., Chen J., Sparkman N.L.J.O.C., Castanon N., Kelley K.W., Dantzer R., Johnson R.W. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology 2008, 33:2341-2351.
26. Guillemin G.J. Quinolinic acid, the inescapable neurotoxin. FEBS J. 2012, 279:1356-1365.
27. Henry C.J., Huang Y., Wynne A.M., Godbout J.P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 2009, 23:309-317.
28. Johnson D.R., O'Connor J.C., Dantzer R., Freund G.G. Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15184-15189.
29. Kelley K.W., O'Connor J.C., Lawson M.A., Dantzer R., Rodriguez-Zas S.L., McCusker R.H. Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guerin. Brain Behav. Immun. 2013, 32:63-69.
30. Kumari R., Willing L.B., Krady J.K., Vannucci S.J., Simpson I.A. Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse. J. Cereb. Blood Flow Metab. 2007, 27:710-718.
31. Lawrence C.B., Brough D., Knight E.M. Obese mice exhibit an altered behavioural and inflammatory response to lipopolysaccharide. Dis. Model. Mech. 2012, 5:649-659.
32. Lawson M.A., Parrott J.M., McCusker R.H., Dantzer R., Kelley K.W., O'Connor J.C. Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. J. Neuroinflammation 2013, 10:87.
33. Lin K.I., Johnson D.R., Freund G.G. LPS-dependent suppression of social exploration is augmented in type 1 diabetic mice. Brain Behav. Immun. 2007, 21:775-782.
34. Liu W., Sheng H., Xu Y., Liu Y., Jianqiang L., Ni X. Swimming exercise ameliorates depression-like behavior in chronically stressed rats: relevant to proinflammatory cytokines and IDO activation. Behav. Brain Res. 2013, 242:110-116.
35. Maletic V., Robinson M., Oakes T., Iyengar S., Ball S.G., Russell J. Neurobiology of depression: an integrated view of key findings. Int. J. Clin. Pract. 2007, 61:2030-2040.
36. Moreau M., André C., O'Connor J.C., Dumich S.A., Woods J.A., Kelley K.W., Dantzer R., Lestage J., Castanon N. Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain Behav. Immun. 2008, 22:1087-1095.
37. Moreau M., Lestage J., Verrier D., Mormede C., Kelley K.W., Dantzer R., Castanon N. Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J. Infect. Dis. 2005, 192:537-544.
38. Morgan C.J., Badawy A.A. Effects of a suppression test dose of dexamethasone on tryptophan metabolism and disposition in the rat. Biol. Psychiatry 1989, 25:359-362.
39. Moroni F., Russi P., Gallo-Mezo M.A., Moneti G., Pellicciari R. Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine. J. Neurochem. 1991, 57:1630-1635.
40. Myint A.M., Kim Y.K., Verkerk R., Scharpe S., Steinbusch H., Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J. Affect. Disord. 2007, 98:143-151.
41. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169.
42. Nikodemova M., Watters J.J. Outbred ICR/CD1 mice display more severe neuroinflammation mediated by microglial TLR4/CD14 activation than inbred C57Bl/6 mice. Neuroscience 2011, 190:67-74.
43. O'Connor J.C., André C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., Castanon N., Kelley K.W., Dantzer R. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J. Neurosci. 2009, 29:4200-4209.
44. O'Connor J.C., Lawson M.A., André C., Briley E.M., Szegedi S.S., Lestage J., Castanon N., Herkenham M., Dantzer R., Kelley K.W. Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J. Immunol. 2009, 182:3202-3212.
45. O'Connor J.C., Lawson M.A., André C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14:511-522.
46. O'Connor J.C., Satpathy A., Hartman M.E., Horvath E.M., Kelley K.W., Dantzer R., Johnson R.W., Freund G.G. IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J. Immunol. 2005, 174:4991-4997.
47. Oxenkrug G.F. Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann. N. Y. Acad. Sci. 2010, 1199:1-14.
48. Painsipp E., Kofer M.J., Sinner F., Holzer P. Prolonged depression-like behavior caused by immune challenge: influence of mouse strain and social environment. PLoS ONE 2011, 6:e20719.
49. Raison C.L., Dantzer R., Kelley K.W., Lawson M.A., Woolwine B.J., Vogt G., Spivey J.R., Saito K., Miller A.H. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol. Psychiatry 2010, 15:393-403.
50. Richard E.M., Helbling J.C., Tridon C., Desmedt A., Minni A.M., Cador M., Pourtau L., Konsman J.P., Mormede P., Moisan M.P. Plasma transcortin influences endocrine and behavioral stress responses in mice. Endocrinology 2010, 151:649-659.
51. Rummel C., Inoue W., Poole S., Luheshi G.N. Leptin regulates leukocyte recruitment into the brain following systemic LPS-induced inflammation. Mol. Psychiatry 2010, 15:523-534.
52. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:201-217.
53. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
54. Stone T.W., Stoy N., Darlington L.G. An expanding range of targets for kynurenine metabolites of tryptophan. Trends Pharmacol. Sci. 2013, 34:136-143.
55. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 2008, 11:309-317.
56. Takikawa O., Yoshida R., Yasui H., Hayaishi O. The relationship between plasma kynurenine and indoleamine 2,3-dioxygenase activity in the extrahepatic tissues. Progress in Tryptophan and Serotonin Research 1984, 517-520. Walter de Gruyter and Co., Berlin/New York. H.G. Schlossberger, W. Kochen, B. Linzen, H. Steinhart (Eds.).
57. Tanaka S., Ide M., Shibutani T., Ohtaki H., Numazawa S., Shioda S., Yoshida T. Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J. Neurosci. Res. 2006, 83:557-566.
58. Tong L., Balazs R., Soiampornkul R., Thangnipon W., Cotman C.W. Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol. Aging 2008, 29:1380-1393.
59. van Dam A.M., Poole S., Schultzberg M., Zavala F., Tilders F.J. Effects of peripheral administration of LPS on the expression of immunoreactive interleukin-1 alpha, beta, and receptor antagonist in rat brain. Ann. N. Y. Acad. Sci. 1998, 840:128-138.
60. Viscogliosi G., Andreozzi P., Chiriac I.M., Cipriani E., Servello A., Marigliano B., Ettorre E., Marigliano V. Depressive symptoms in older people with metabolic syndrome: is there a relationship with inflammation?. Int. J. Geriatr. Psychiatry 2013, 28:242-247.
61. Walker A.K., Budac D.P., Bisulco S., Lee A.W., Smith R.A., Beenders B., Kelley K.W., Dantzer R. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology 2013, 38:1609-1616.
62. Wang Y., Lawson M.A., Dantzer R., Kelley K.W. LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia. Brain Behav. Immun. 2009, 24:201-209.
63. Wynne A.M., Henry C.J., Huang Y., Cleland A., Godbout J.P. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav. Immun. 2010, 24:1190-1201.
64. Zunszain P.A., Anacker C., Cattaneo A., Choudhury S., Musaelyan K., Myint A.M., Thuret S., Price J., Pariante C.M. Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 2012, 37:939-949.